Summary
Merck & Co., Inc. (MRK) filed an 8-K report on July 29, 2011, primarily to report its financial results for the second quarter of 2011 and to announce significant updates to its global restructuring program. The company detailed ongoing integration efforts following the merger with Schering-Plough, including the next phase of workforce reductions aimed at optimizing its cost structure. These restructuring actions are expected to continue through 2013 and potentially 2015 for certain manufacturing components, with an estimated cumulative pretax cost of $5.8 billion to $6.6 billion. Investors should note that while the company is undertaking substantial restructuring, it also anticipates significant annual savings upon completion, projected to be between $4.0 billion and $4.6 billion. The filing also incorporated by reference a press release and supplemental information detailing the second-quarter 2011 earnings, though the specifics of these financial results are not detailed within the 8-K text itself.
Key Highlights
- 1Merck announced the next phase of its global restructuring program, stemming from the integration of legacy Merck and Schering-Plough businesses.
- 2The company plans to reduce its workforce by an additional 12% to 13% worldwide.
- 3These workforce reductions will primarily impact manufacturing, Animal Health, administrative, and headquarters organizations.
- 4The total estimated cumulative pretax costs for the Merger Restructuring Program are now expected to be between $5.8 billion and $6.6 billion.
- 5Merck recorded an $808 million charge in Q2 2011 for certain restructuring costs.
- 6The program is expected to yield annual savings of $4.0 billion to $4.6 billion upon completion.
- 7The 8-K incorporates by reference Merck's Q2 2011 earnings press release and supplemental financial information.